Protein & Cell >

2019 , Vol. 10 >Issue 6: 455 - 460

DOI: https://doi.org/10.1007/s13238-018-0606-8

LETTER

The effect of clinical-grade retinal pigment epithelium derived from human embryonic stem cells using different transplantation strategies

  • Lei Wang 1,2,4,6 ,
  • Wei Wu 3 ,
  • Qi Gu 5 ,
  • Zengping Liu 3 ,
  • Qiyou Li 3 ,
  • Zhongwen Li 1,2,4,6 ,
  • Jinhui Fang 2,4,6 ,
  • Wenjing Liu 2,4,6 ,
  • Jun Wu 2,4,6 ,
  • Ying Zhang 2 ,
  • Liu Wang 1,2,4,6 ,
  • Haiwei Xu 3 ,
  • Wei Li 1,2,4,6 ,
  • Baoyang Hu 1,2,4,6 ,
  • Qi Zhou , 1,2,4,6 ,
  • Zhengqin Yin , 3 ,
  • Jie Hao , 2,4,6
Expand
  • 1. Savaid Medical School, University of Chinese Academy of Sciences, Beijing 100049, China
  • 2. State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China
  • 3. Southwest Hospital/Southwest Eye Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China
  • 4. Beijing Stem Cell Bank, Chinese Academy of Sciences, Beijing 100190, China
  • 5. State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China
  • 6. Stem Cell and Regenerative Medicine Innovation Institute, Chinese Academy of Sciences, Beijing 100101, China

Published date: 15 Jun 2019

Copyright

2019 The Author(s)
Fold

Cite this article

Lei Wang , Wei Wu , Qi Gu , Zengping Liu , Qiyou Li , Zhongwen Li , Jinhui Fang , Wenjing Liu , Jun Wu , Ying Zhang , Liu Wang , Haiwei Xu , Wei Li , Baoyang Hu , Qi Zhou , Zhengqin Yin , Jie Hao . The effect of clinical-grade retinal pigment epithelium derived from human embryonic stem cells using different transplantation strategies[J]. Protein & Cell, 2019 , 10(6) : 455 -460 . DOI: 10.1007/s13238-018-0606-8

References

Publishing order | Descend order by publishing year | Descend order by cited within
1
Andrews PW, Cavagnaro J, Deans R, Feigal E, Horowitz E, Keating A, Rao M, Turner M, Wilmut I, Yamanaka S (2014) Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells. Nat Biotechnol 32:724–726

DOI

2
Diniz B, Thomas P, Thomas B, Ribeiro R, Hu Y, Brant R, Ahuja A, Zhu D, Liu L, Koss M (2013) Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: improved survival when implanted as a monolayer. Invest Ophthalmol Vis Sci 54:5087–5096

DOI

3
da Cruz L, Fynes K, Georgiadis O, Kerby J, Luo YH, Ahmado A, Vernon A, Daniels JT, Nommiste B, Hasan SM (2018) Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration. Nat Biotechnol 36:328–337

DOI

4
Gu Q, Wang J, Wang L, Liu ZX, Zhu WW, Tan YQ, Han WF, Wu J, Feng CJ, Fang JH (2017) Accreditation of biosafe clinicalgrade human embryonic stem cells according to Chinese regulations. Stem Cell Reports 9:366–380

DOI

5
Kashani AH, Lebkowski JS, Rahhal FM, Avery RL, Salehi-Had H, Dang W, Lin CM, Mitra D, Zhu D, Thomas BB (2018) A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration. Sci Transl Med 10: eaao4097

DOI

6
Kuriyan AE, Albini TA, Townsend JH, Rodriguez M, Pandya HK, Leonard RE 2nd, Parrott MB, Rosenfeld PJ, Flynn HW Jr, Goldberg JL (2017) Vision loss after intravitreal injection of autologous “stem cells” for AMD. N Engl J Med 376:1047–1053

DOI

7
Liu Y, Xu HW, Wang L, Li SY, Zhao CJ, Hao J, Li QY, Zhao TT, Wu W, Wang Y (2018) Human embryonic stem cell-derived retinal pigment epithelium transplants as a potential treatment for wet age-related macular degeneration. Cell Discov 4:50

DOI

8
Maruotti J, Wahlin K, Gorrell D, Bhutto I, Lutty G, Zack DJ (2013) A simple and scalable process for the differentiation of retinal pigment epithelium from human pluripotent stem cells. Stem Cells Transl Med 2:341–354

DOI

9
Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, Mickunas E, Gay R, Klimanskaya I, Lanza R (2012) Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379:713–720

DOI

10
Schwartz SD, Regillo CD, Lam BL, Eliott D, Rosenfeld PJ, Gregori NZ, Hubschman JP, Davis JL, Heilwell G, Spirn M (2015) Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt’s macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet 385:509–516

DOI

11
Song WK, Park KM, Kim HJ, Lee JH, Choi J, Chong SY, Shim SH, Del Priore LV, Lanza R (2015) Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in Asian patients. Stem Cell Reports 4:860–872

DOI

12
Stanzel BV, Liu Z, Somboonthanakij S, Wongsawad W, Brinken R, Eter N, Corneo B, Holz FG, Temple S, Stern JH (2014) Human RPE stem cells grown into polarized RPE monolayers on a polyester matrix are maintained after grafting into rabbit subretinal space. Stem Cell Reports 2:64–77

DOI

13
Strauss O (2005) The retinal pigment epithelium in visual function. Physiol Rev 85:845–881

DOI

14
Unger C, Skottman H, Blomberg P, Dilber MS, Hovatta O (2008) Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum Mol Genet 17:R48–R53

DOI

Options
Outlines

/

〈 〉